LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

Written By Mollie Rotmensch

Deng M. et al. Nature. 2018; 562: 605–609.

Mollie Rotmensch
Previous

Targeting the immune inhibitory receptor LILRB4 to treat acute myeloid leukemia (AML)
Next

A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML